title: [Exacerbations of asthma in pregnant women].
abstract: Prevention of exacerbations and effective treatment is essential in pregnant asthmatic women. The management is well documented. Misunderstanding of the recommendations leads to unsuitable, insufficient treatment and is responsible for more frequent recurrences in the pregnant woman compared with the non pregnant. Above all, good control of the disease and the prevention of exacerbations, based on inhaled corticosteroid therapy and smoking cessation, reduces complications, in particular prematurity and low birth weight.
authors: Service de pneumologie, CHG de Bigorre, 65013 Tarbes, France. ap@ch-Tarbes-vic.fr
authors: A
authors: A
authors: Prudhomme
authors: S
authors: S
authors: Frys
authors: I
authors: I
authors: Tillie-Leblond
mesh_terms: D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000503:physiopathology* / Q000628:therapy; D015331:Cohort Studies; D004417:Dyspnea / Q000209:etiology / Q000517:prevention & control; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D015201:Meta-Analysis as Topic; D009765:Obesity / Q000150:complications; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D010102:Oxygen Inhalation Therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000503:physiopathology* / Q000517:prevention & control / Q000628:therapy; D012008:Recurrence; D012307:Risk Factors; D016540:Smoking Cessation
chemical_list: D018927:Anti-Asthmatic Agents